REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 644-647

  Kumari, Rashmi ^a   Willing, Lisa B ^a   Jefferson, Leonard S ^a   Simpson, Ian A ^a   Kimball, Scot R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Corticosterone; Diabetes; Glucocorticoid; REDD1; RU 486; Stroke

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; PEPTIDES AND PROTEINS; REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSE 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; GENETIC TRANSCRIPTION; HYPERCORTISOLISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SKELETAL MUSCLE; STROKE;

ANIMALS; BIOMARKERS, PHARMACOLOGICAL; DNA DAMAGE; GLUCOCORTICOIDS; MALE; MICE; MIFEPRISTONE; MUSCLE, SKELETAL; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTORS;

EID: 80052635943     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.017     Document Type: Article

References (18)

1. Rose A.J., Vegiopoulos A., Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: Insights from genetic manipulations. J. Steroid Biochem. Mol. Biol. 2010, 122:10-20.
2. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol. Cell. Endocrinol. 2007, 275:43-61.
3. Dryden S., Burns S.J., Frankish H.M., Williams G. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids. Eur. J. Pharmacol. 1997, 340:221-225.
4. Wang H., Kubica N., Ellisen L.W., Jefferson L.S., Kimball S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J. Biol. Chem. 2006, 281:39128-39134.
5. McGhee N.K., Jefferson L.S., Kimball S.R. Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor REDD1. J. Nutr. 2009, 139:828-834.
6. Kumari R., Willing L.B., Krady J.K., Vannucci S.J., Simpson I.A. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab. 2007, 27:710-718.
7. Vannucci S.J., Willing L.B., Goto S., Alkayed N.J., Brucklacher R.M., Wood T.L., Towfighi J., Hurn P.D., Simpson I.A. Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 2001, 21:52-60.
8. Nair A., Bonneau R.H. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 2006, 171:72-85.
9. Kimball S.R., Do A.N.D., Kutzler L., Cavener D.R., Jefferson L.S. Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. J. Biol. Chem. 2008, 283:3465-3475.
10. Kumari R., Willing L.B., Patel S.D., Krady J.K., Zavadoski W.J., Gibbs E.M., Vannucci S.J., Simpson I.A. The PPAR-γ agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J. Cereb. Blood Flow Metab. 2010, 30:352-360.
11. Bitar M.S. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am. J. Pathol. 1998, 152:547-554.
12. Yang B., Trump R.P., Shen Y., McNulty J.A., Clifton L.G., Stimpson S.A., Lin P., Pahel G.L. RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice. BMC Pharmacol. 2008, 8:7.
13. Gaillard R.C., Riondel A., Muller A.F., Herrmann W., Baulieu E.E. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc. Natl. Acad. Sci. USA 1984, 81:3879-3882.
14. Healy D.L., Chrousos G.P., Schulte H.M., Gold P.W., Hodgen G.D. Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships. J. Clin. Endocrinol. Metab. 1985, 60:1-4.
15. Shimizu N., Yoshikawa N., Ito N., Maruyama T., Suzuki Y., Takeda S.-i., Nakae J., Tagata Y., Nishitani S., Takehana K., Sano M., Fukuda K., Suematsu M., Morimoto C., Tanaka H. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 2011, 13:170-182.
16. Wu Y., Zhao W., Zhao J., Zhang Y., Qin W., Pan J., Bauman W.A., Blitzer R.D., Cardozo C. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 2010, 151:1050-1059.
17. Wang H., Kubica N., Ellisen L.W., Jefferson L.S., Kimball S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J. Biol. Chem. 2006, 281:39128-39134.
18. Uchikawa K., Takahashi H., Hase K., Masakado Y., Liu M. Strenuous exercise-induced alterations of muscle fiber cross-sectional area and fiber-type distribution in steroid myopathy rats. Am. J. Phys. Med. Rehabil. 2008, 87:126-133.